[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362579-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362579-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-risks-and-trends-between-1997-and-2018-and-effects-of-restored-immunity-in-people-living-with-hiv-results-from-the-anrs-co4-french-hospital-database-on-hiv","Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV","","Long-term trends in cancer incidence were evaluated among people with HIV in France from 1997 to 2018, with emphasis on AIDS-defining cancers (Kaposi’s sarcoma, non-Hodgkin’s lymphoma, and cervical cancer) and additional virus-related, virus-unrelated, and non-AIDS-defining cancers. Data from the ANRS CO4-French Hospital Database on HIV and cancer registries informed age-standardized incidence rates and standardized incidence ratios across four time periods. In 154,733 individuals contributing nearly 2 million person-years, 9,572 cancers were diagnosed. Incidence rates of AIDS-defining and virus-related non-AIDS-defining cancers declined over time but stayed higher than the general population, and controlled-HIV immune restoration reduced—yet did not eliminate—excess risks.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-risks-and-trends-between-1997-and-2018-and-effects-of-restored-immunity-in-people-living-with-hiv-results-from-the-anrs-co4-french-hospital-database-on-hiv/362579/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-risks-and-trends-between-1997-and-2018-and-effects-of-restored-immunity-in-people-living-with-hiv-results-from-the-anrs-co4-french-hospital-database-on-hiv/362579.png","ImageObject",300,407,{"name":42,"@type":43},"Aria Callaghan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cancers were prioritized in this study among people living with HIV?","Question",{"text":63,"@type":64},"The study focused on AIDS-defining cancers: Kaposi’s sarcoma, non-Hodgkin’s lymphoma, and cervical cancer, and also evaluated virus-related non-AIDS-defining, virus-unrelated, and other cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cancer risks quantified across the 1997–2018 period?",{"text":68,"@type":64},"Age-standardized incidence rates and standardized incidence ratios (SIRs) were calculated across four time periods using ANRS CO4-French Hospital Database on HIV data linked with general-population cancer registries.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the effect of immune control (restored CD4 and suppressed viral load) on cancer risks?",{"text":72,"@type":64},"Among participants with CD4 ≥ 500/mm3 for at least 2 years and recent viral load ≤ 50 copies/mL, risks of virus-related cancers remained significantly higher than in the general population but were reduced compared with risks in people with HIV overall.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362579,1790194246,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10.1002/ijc.70253  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nCancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV  \nSophie Grabar 1  | Paula Lakrout 2 | Valérie Potard 2 | Aurélien Belot 3  | Jacques Cadranel 4  | Christine Jacomet 5 | Christine Katlama 2,6 |  \nEsaïe Marshall 2 | Olivier Lambotte 7 | Romain Palich 2,8 | Sylvie Ronot-Bregigeon 9 | Jean-Philippe Spano 1,10 |  \nAnne-Marie Bouvier 11,12,13,14,15  | Alain Makinson 16 | Dominique Costagliola 2 1Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Paris, France  \n2Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France  \n3Inequalities in Cancer Outcomes Network (ICON), Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK  \n4AP-HP, Hôpital Tenon, Service de Pneumologie et Oncologie Thoracique, GRCO4 Theranoscan, Sorbonne Université, Paris, France 5Infectious Diseases Department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France  \n6AP-HP, Hôpital Pitié Salpêtrière, Service de Maladies Infectieuses et Tropicales, Paris, France  \n7Université Paris Saclay, AP-HP, Service de Médecine Interne Immunologie Clinique, Hôpital de Bicêtre, Inserm, Le Kremlin Bicêtre, France 8Infectious Diseases Department, Hôtel-Dieu Hospital, AP-HP, Paris Cité University, Paris, France  \n9APHM, Hôpital Sainte-Marguerite, Aix-Marseille Université, Marseille, France 10AP-HP, Hôpital Pitié Salpêtrière, Service d'oncologie Médicale, Paris, France 11Digestive Cancer Registry of Burgundy, Dijon, France  \n12French Network of Cancer Registries (FRANCIM), Dijon, France 13Dijon University Hospital, Dijon, France  \n14INSERM UMR 1231, EPICAD, Dijon, France  \n15Université de Bourgogne, INSERM UMR 1231, EPICAD, Dijon, France  \n16CHU Montpellier, Service de Maladies Infectieuse et tropicale, Université de Montpellier, Montpellier, France  \nCorrespondence  \nSophie Grabar, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Hôpital St Antoine, Paris, France. Email: [sophie.grabar@iplesp.upmc.fr](sophie.grabar@iplesp.upmc.fr)  \nAbstract  \nWe assessed long-term trends in cancer incidence among people with HIV (PWH) in France between 1997 and 2018, focusing on AIDS-defining cancers (ADC) (Kaposi's sarcoma, non-Hodgkin's lymphoma, and cervical cancer), three virus-related  \nAbbreviations: ADC, AIDS-defining cancers; ANRS CO4 FHDH, the French Hospital Database on HIV; cART, combination antiretroviral therapy; CNIL, Commission Nationale de l'Informatique et des Libertés; EGB, Echantillon généraliste des Bénéficiaires; FRANCIM,(France Cancer Incidence et Mortalité) French Network of Cancer Registries; HBV, hepatitis B virus; HCP, Healthcare Coverage Program; HCV, hepatitis C virus; HL, Hodgkin's lymphoma; ICD-10, International Classification of Diseases, Tenth Revision; IQR, interquartile range; IR, incidence rate; KS, Kaposi's sarcoma; MSM, men who have sex with men; NADC, non AIDS-defining cancers; NHL, non-Hodgkin lymphoma; PWH, person with HIV; PY, person-years; SIR, Standardized Incidence Ratio.  \nAlain Makinson and Dominique Costagliola contributed equally.  \nPrevious Presentation: Part of this work has been presented at the 19th European AIDS Conference, 18–21 October 2023 in Warsaw, Poland.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \nFunding information  \nAgence Nationale de Recherche sur le Sida et les hépatites virales-Maladies Infectieuses Emergentes, Grant","cbCaih3au6rBuz9I","https://ap.wps.com/l/cbCaih3au6rBuz9I","pdf",5119166,11,"English","# Abstract\n## Study design and data sources\n## Main findings on incidence trends\n## Effects of controlled viral load and restored CD4\n## Cancer-type specific patterns","[{\"question\":\"Which cancers were prioritized in this study among people living with HIV?\",\"answer\":\"The study focused on AIDS-defining cancers: Kaposi’s sarcoma, non-Hodgkin’s lymphoma, and cervical cancer, and also evaluated virus-related non-AIDS-defining, virus-unrelated, and other cancer types.\"},{\"question\":\"How were cancer risks quantified across the 1997–2018 period?\",\"answer\":\"Age-standardized incidence rates and standardized incidence ratios (SIRs) were calculated across four time periods using ANRS CO4-French Hospital Database on HIV data linked with general-population cancer registries.\"},{\"question\":\"What was the effect of immune control (restored CD4 and suppressed viral load) on cancer risks?\",\"answer\":\"Among participants with CD4 ≥ 500/mm3 for at least 2 years and recent viral load ≤ 50 copies/mL, risks of virus-related cancers remained significantly higher than in the general population but were reduced compared with risks in people with HIV overall.\"}]","Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV | PDF",1790148398,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ac576bb22c92fc0a93eb154f00c54af.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b44b413aac266f01dcf284e265112af.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84987bcdcb8bd092e2c200e58f7ab138.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/719cd4a4140459b80a5d8b98a32dbb6d.webp",980,1287]